Comparison
Saffron vs Kanna
Saffron
Crocus stigma — most expensive spice. Increasingly evidence-based antidepressant comparable to SSRIs at low doses.
Kanna
Sceletium tortuosum — South African succulent. Acts as serotonin reuptake inhibitor and PDE4 inhibitor.
| Field | Saffron | Kanna |
|---|---|---|
| Category | adaptogen | adaptogen |
| Dose range | 28–30mg | 25–50mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●○ | ●●●○○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 1700 | 50 |
The comparison in plain English
Auto-generated from dataSaffron and Kanna are both in the adaptogen category respectively. Saffron Crocus stigma — most expensive spice. Kanna Sceletium tortuosum — South African succulent.
Bottom line
Saffron (evidence A, safety 4/5) has a weaker evidence base than Kanna (evidence B, safety 3/5). Saffron has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Saffron if
Saffron is the better fit when your goal aligns with its mechanism (Crocin (carotenoid responsible for the red colour) and safranal (volatile compound responsible for the aroma) both inhibit serotonin and dopamine reuptake at neurochemically meaningful concentrations) and the dose range (28–30mg) suits your protocol. Half-life is —h.
Choose Kanna if
Kanna is the better fit when your goal aligns with its mechanism (Mesembrine and related alkaloids inhibit serotonin reuptake (similar to SSRI mechanism but at much lower potency) and PDE4 (similar to rolipram)) and the dose range (25–50mg) suits your protocol. Half-life is —h.